Average Co-Inventor Count = 1.25
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-farber-cancer Institute Inc. (13 from 1,209 patents)
2. The Brigham and Women's Hospital, Inc. (2 from 1,373 patents)
3. Northeastern University (2 from 755 patents)
4. The Broad Institute, Inc. (1 from 443 patents)
13 patents:
1. 11725230 - Selective degradation of wild-type DNA and enrichment of mutant alleles using nuclease
2. 11371090 - Compositions and methods for molecular barcoding of DNA molecules prior to mutation enrichment and/or mutation detection
3. 11174510 - Full COLD-PCR enrichment with reference blocking sequence
4. 11174511 - Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture
5. 11130992 - Methods and compositions to enable multiplex COLD-PCR
6. 10913977 - Methods and compositions to enable enrichment of minor DNA alleles by limiting denaturation time in PCR or simply enable enrichment of minor DNA alleles by limiting the denaturation time in PCR
7. 10835604 - Biomaterials for combined radiotherapy and immunotherapy of cancer
8. 10799604 - Biopolymer-nanoparticle composite implant for tumor cell tracking
9. 9957556 - Full COLD-PCR enrichment with reference blocking sequence
10. 8623603 - Full cold-PCR enrichment with reference blocking sequence
11. 8455190 - Enrichment of a target sequence
12. 7033757 - Mutation scanning array, and methods of use thereof
13. 6174680 - Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof